COSMOS HEALTH INC (COSM)
US2214133058 - Common Stock
We assign a fundamental rating of 3 out of 10 to COSM. COSM was compared to 114 industry peers in the Health Care Providers & Services industry. COSM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. COSM is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
COSM had negative earnings in the past year.
In the past year COSM has reported a negative cash flow from operations.
In the past 5 years COSM reported 4 times negative net income.
In the past 5 years COSM always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -59.98%, COSM is doing worse than 88.50% of the companies in the same industry.
Looking at the Return On Equity, with a value of -96.27%, COSM is doing worse than 75.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.98% | ||
| ROE | -96.27% | ||
| ROIC | N/A |
ROA(3y)-41.22%
ROA(5y)-36.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 7.19%, COSM is not doing good in the industry: 79.65% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of COSM has grown nicely.
The Profit Margin and Operating Margin are not available for COSM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 7.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.67%
GM growth 5Y12.63%
2. Health
2.1 Basic Checks
COSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
COSM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, COSM has more shares outstanding
Compared to 1 year ago, COSM has an improved debt to assets ratio.
2.2 Solvency
COSM has an Altman-Z score of -0.76. This is a bad value and indicates that COSM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COSM (-0.76) is worse than 76.11% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that COSM is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.20, COSM is doing good in the industry, outperforming 70.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.76 |
ROIC/WACCN/A
WACC5.79%
2.3 Liquidity
A Current Ratio of 2.06 indicates that COSM has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.06, COSM is doing good in the industry, outperforming 76.11% of the companies in the same industry.
A Quick Ratio of 1.79 indicates that COSM should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.79, COSM is doing good in the industry, outperforming 70.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.79 |
3. Growth
3.1 Past
COSM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.89%, which is quite impressive.
Looking at the last year, COSM shows a decrease in Revenue. The Revenue has decreased by -8.99% in the last year.
Measured over the past years, COSM shows a quite strong growth in Revenue. The Revenue has been growing by 10.90% on average per year.
EPS 1Y (TTM)82.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.15%
Revenue 1Y (TTM)-8.99%
Revenue growth 3Y8.26%
Revenue growth 5Y10.9%
Sales Q2Q%6.69%
3.2 Future
The Earnings Per Share is expected to grow by 40.91% on average over the next years. This is a very strong growth
COSM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.85% yearly.
EPS Next Y98.03%
EPS Next 2Y40.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y13.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
COSM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year COSM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
COSM's earnings are expected to grow with 40.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.91%
EPS Next 3YN/A
5. Dividend
5.1 Amount
COSM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
COSMOS HEALTH INC
NASDAQ:COSM (6/17/2024, 7:00:00 PM)
After market: 0.6762 -0.02 (-3.26%)0.699
+0.04 (+5.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.83M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.98% | ||
| ROE | -96.27% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 7.19% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.79 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)82.89%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y98.03%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-8.99%
Revenue growth 3Y8.26%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y